FDA inspection
Chongqing Lummy Pharmaceutical Co. Ltd.: FDA inspection ending Mar 17, 2016
FDA inspection 961769 · Official Action Indicated (OAI) · Chongqing
Key facts
| Inspection ID | 961769 |
|---|---|
| Firm | Chongqing Lummy Pharmaceutical Co. Ltd. |
| FEI number | 3006560479 |
| Address | Economic And Technological , NO. 2 the 4th Branch Rd, Huaa??Nan Road |
| City | Chongqing |
| Country | China |
| Fiscal year | 2016 |
| Inspection end date | Mar 17, 2016 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 494702 |
At a glance
- None Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data